TORONTO, ONTARIO--(Marketwired - Nov 29, 2016) - Trillium Therapeutics Inc. (
The conference call may be accessed by dialing:
- U.S. callers: (844) 358-6757
- International callers: (216) 562-0400
- Conference ID: 28772974.
The conference call will also be available via a live webcast on the investors section of Trillium's website at